US federal and state laws conflicting over generic ADRs

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1359, 2011-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Action in the courts over ADRs

By  

Reactions Weekly, Vol. 1, Iss. 1294, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The US Federal Trade Commission (FTC) is concerned that major pharma companies are once again paying to defer generic drug launches

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 503, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

US sees a rise in ADRs and medication errors

By  

Reactions Weekly, Vol. 1, Iss. 1348-1349, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

US generic approvals

By  

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Change in generic substitution laws could save costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 608, 2010-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite